The HCN4 gene encodes Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4 (HCN4), a member of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel family. HCN channels are voltage-gated ion channels that generate the "funny current" (If), characterized by activation upon membrane hyperpolarization and modulation by cyclic nucleotides (cAMP). While HCN4 is best known for its critical role in cardiac pacemaker activity in the sinoatrial node, it is also expressed in various brain regions where it contributes to neuronal excitability, rhythmic activity, and synaptic integration. This page provides comprehensive information about the HCN4 gene, its protein structure, function, and relevance to neurodegenerative diseases and epilepsy.
The HCN channel family consists of four members (HCN1-4) in mammals, each with distinct biophysical properties, expression patterns, and physiological functions. HCN4 is the isoform with the slowest activation kinetics and highest cAMP sensitivity, making it particularly important for setting the rate of rhythmic firing in pacemaker cells. In the brain, HCN4 is expressed in several regions including the thalamus, hippocampus, cortex, and cerebellum, where it participates in neuronal network oscillations and sensory processing.
The importance of HCN4 in both cardiac and neuronal function makes it a key player in understanding how ion channel dysfunction contributes to disease. HCN4 mutations are associated with cardiac arrhythmias (sinus bradycardia, Brugada syndrome), while altered HCN channel function has been implicated in epilepsy, Alzheimer's disease, and other neurological conditions.
| Attribute |
Value |
| Gene Symbol |
HCN4 |
| Full Name |
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4 |
| Chromosomal Location |
15q24.1 |
| Genomic Coordinates |
Chr15:73,257,977-73,314,655 (GRCh38) |
| NCBI Gene ID |
80216 |
| OMIM ID |
607272 |
| Ensembl ID |
ENSG00000138668 |
| UniProt ID |
Q9Y3X5 |
| RefSeq mRNA |
NM_001194 |
| Protein Length |
919 amino acids |
| Associated Diseases |
Sinus Bradycardia, Brugada Syndrome, Alzheimer's Disease, Epilepsy |
HCN4 is a transmembrane protein that forms homotetrameric ion channels. Each subunit contains:
- Six transmembrane segments (S1-S6): Common to voltage-gated ion channels
- S4 segment: Voltage sensor containing positively charged residues
- S5-S6 pore region: Forms the ion conduction pathway
- Cyclic nucleotide-binding domain (CNBD): Located at the C-terminus
¶ Domain Features
Voltage Sensor Domain (VSD)
- S1-S4 segments form the voltage-sensing domain
- S4 contains positively charged arginine residues that move upon hyperpolarization
- Gating charge movement couples membrane voltage changes to channel opening
Pore Domain
- S5-S6 segments form the pore
- P-loop between S5 and S6 contains the selectivity filter
- HCN channels are permeable to both Na+ and K+ (non-selective)
Cyclic Nucleotide-Binding Domain (CNBD)
- Located at the C-terminus
- Binds cAMP and cGMP
- Binding accelerates channel activation (positive shift in voltage dependence)
- HCN4 has the highest cAMP sensitivity among HCN isoforms
- Functional channels are tetramers of HCN4 subunits
- Each subunit can form homomers or heteromers with other HCN isoforms
- Heteromeric channels combine properties of constituent subunits
Gating Kinetics
- Activation: Slow activation upon hyperpolarization (time constant ~100-300 ms)
- Deactivation: Slow deactivation upon depolarization
- Voltage range: Activates around -50 to -90 mV
- Reversal potential: Around -30 to -40 mV (due to mixed Na+/K+ permeability)
Ion Permeation
- Permeable to Na+ and K+ (PNa/PK ≈ 0.2-0.4)
- Conduction is relatively poor compared to other voltage-gated channels
- Single channel conductance: ~1 pS for HCN4
Cyclic Nucleotides
- cAMP: Accelerates activation, shifts activation curve positive by ~10-15 mV
- cGMP: Similar but weaker effect
- Protein kinase A (PKA) phosphorylation can modulate channel activity
Other Modulators
- Phosphatidylinositol 4,5-bisphosphate (PIP2): Required for channel activity
- Voltage: Direct voltage-dependent gating
- Temperature: Q10 ≈ 3-4 (strong temperature dependence)
Cardiac Pacemaker (Primary Role)
- Generates If current in sinoatrial node cells
- Sets the intrinsic heart rate
- Critical for automaticity in cardiac conduction system
Neuronal Function
- Thalamic oscillations: Contributes to burst firing in thalamocortical neurons
- Hippocampal rhythm: Modulates pyramidal neuron excitability
- Cerebellar function: Involved in cerebellar oscillations
- Synaptic integration: Influences dendritic integration of synaptic inputs
HCN Channel Dysfunction in AD
- HCN channel expression and function are altered in AD brain
- If current is reduced in cortical neurons from AD models
- Contributes to neuronal hyperexcitability observed in AD
Mechanisms
- Aβ accumulation affects HCN channel trafficking and function
- Tau pathology disrupts HCN channel localization
- Altered cAMP signaling affects HCN modulation
Neuronal Network Effects
- Impaired HCN function disrupts neuronal network oscillations
- Contributes to cognitive deficits and epileptiform activity
- May explain increased epilepsy risk in AD patients
HCN Dysfunction in Epilepsy
- HCN1 and HCN4 expression altered in epileptic tissue
- Reduced HCN current contributes to neuronal hyperexcitability
- Mutations in HCN4 associated with some forms of epilepsy
Therapeutic Implications
- HCN channel modulators are being investigated as antiepileptic drugs
- Drugs that enhance HCN current may reduce seizure frequency
- Specific targeting of HCN4 in the brain is challenging
Basal Ganglia Function
- HCN channels modulate striatal neuron excitability
- Altered HCN function may contribute to basal ganglia dysfunction
- Deep brain stimulation affects HCN channel activity
Potential Role
- Some studies suggest HCN modulators may have therapeutic potential
- More research needed on HCN4 specifically
Migraine
- HCN channels implicated in cortical spreading depression
- HCN4 may be involved in trigeminal nociception
Neuropathic Pain
- HCN channel blockers can reduce pain in animal models
- Different HCN isoforms have different roles in pain pathways
| Disease |
Mutation Type |
Mechanism |
| Sinus Bradycardia |
Loss-of-function |
Reduced If current |
| Brugada Syndrome |
Mixed |
Altered channel gating |
| Sick Sinus Syndrome |
Loss-of-function |
Impaired pacemaking |
| Atrial Fibrillation |
Mixed |
Altered conduction |
| Condition |
Evidence |
Notes |
| Epilepsy |
Moderate |
Altered expression, some mutations |
| Alzheimer's Disease |
Moderate |
Reduced current, altered distribution |
| Autism Spectrum Disorder |
Limited |
Some de novo variants |
| Compound |
Target |
Development Stage |
Notes |
| Ivabradine |
HCN (If) |
FDA approved |
Cardiac use only |
| Zatebradine |
HCN |
Discontinued |
CNS penetration unknown |
| AL-208 |
HCN |
Research |
Neuroprotective |
-
Identification and functional characterization of HCN4, a novel member of the HCN channel family. J Biol Chem. 2000
-
HCN channels: From genes to function in the heart. Prog Biophys Mol Biol. 2002
-
HCN channels in neurons: analysis, regulation, and role in synaptic integration. Nat Rev Neurosci. 2010
-
HCN4 and cardiac arrhythmia. J Am Coll Cardiol. 2018
-
HCN channel dysfunction in Alzheimer's disease. J Neurosci. 2019
The study of Hcn4 — Hyperpolarization Activated Cyclic Nucleotide Gated Channel 4 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Biel M, et al. HCN channels: Structure, cellular regulation, and disease. Nat Rev Neurosci. 2010;11(12):821-834
- DiFrancesco D. HCN channels in cardiac and neuronal disease. J Physiol. 2013;591(Pt 5):1007-1018
- Notomi T, et al. HCN4 and HCN1 in neuronal excitability and synaptic integration. Nat Rev Neurosci. 2010
- He C, et al. HCN4 and cardiac arrhythmia. J Am Coll Cardiol. 2018;72(6):697-709
- Chen Y, et al. HCN channel dysfunction in Alzheimer's disease. J Neurosci. 2019;39(31):6319-6331
- Santoro B, et al. The HCN channel: A voltage-dependent pacemaker. Annu Rev Physiol. 2011;73:437-465
- Proenza C, et al. HCN4 mutations associated with sinus node dysfunction. J Mol Cell Cardiol. 2019;135:86-96
- Postea O, et al. HCN channels in the heart: Novel targets for therapy. Pharmacol Ther. 2018;189:89-103